Donor Egg IVF Treatment Market

Market Insights

The donor egg IVF treatment market is expected to reach $3,676.8 million by 2027, up from $1,782.1 million in 2018, indicating moderate growth at an 8.4% compound annual growth rate (CAGR) from 2019 to 2027.

In the last two decades, there has been a paradigm shift in society that has had a major influence on the consistently growing infertility rate. A significant rise in working women, delayed marriages, advanced maternal age, etc., provides a positive impetus for the donor egg IVF treatment market.

Market Synopsis

The fresh donor egg IVF cycle market is derived from high pregnancy success rates and efficiency in retrieving viable embryos.

Fresh donor egg IVF cycles are reigning in the cycle-type segment of the donor egg IVF treatment market. The advantages associated with a fresh donor egg IVF treatment cycle are the high success rate associated with pregnancy and the efficient method of retrieving viable embryos.

The limitation associated with this cycle type is the long waiting period. The frozen donor egg IVF cycle market is gaining traction on account of effective screening and consistent cohorts ready to be shipped, thawed, and used as per a client’s schedule. Changes in lifestyle and family planning motivate people to freeze eggs for future children and siblings.

The fertility clinics market is growing due to technological advancements in IVF treatment protocols and state-of-the-art capital equipment.

Fertility clinics are dominating the end-user segment of the donor egg IVF treatment market. Inherent features such as technological advancement in IVF treatment protocols such as egg freezing, hatching, vitrification, intrafallopian gamete transfer (GIFT), etc., provide the necessary impetus for the market growth of fertility clinics worldwide.

Healthcare organizations in developed countries are providing significant financial assistance to establish IVF treatment centers in hospitals to serve people in remote areas.

The rising prevalence of menopause and rising public health awareness about infertility drive market growth in North America.

North America, with a market share of 34%, is the leading regional segment for the donor egg IVF treatment market. The rising prevalence of menopause is the primary cause of its dominance. As per the statistics provided by the American Congress of Obstetricians and Gynecologists, approximately 2 million women reach early menopause annually. Increasing public health awareness related to infertility will propel market growth in the region.

Europe accounts for 32% of the market share, owing to a change in lifestyle that prioritizes a professional career over a personal life and, hence, opts for late-stage pregnancy induced via IVF treatment. Asia Pacific is representing 24% market growth on account of a significant rise in fertility clinics and increasing fertility tourism as IVF treatment is now available at an affordable price.

Periods of History and Forecast

This research report presents the analysis of each segment from 2017 to 2027,considering 2018as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market segmentation for the scope of the report is done by cycle type, end user, and geography.

Pharmaceutical companies specializing in providing IVF treatment services are Cook Medical, Inc., EMD Serono, Inc., Flinders Reproductive Medicine Pty. Ltd., Fertility First, Genea Oxford Fertility Limited, OvaScience, Procrea Fertility, Progyny, Inc., ReproMed, and Vitrolife AB.

Key questions are answered in this report.

• Which major players are competing in the donor egg IVF treatment market?
• What are the organic and inorganic market growth strategies to determine the latest market trend?
• What are the different factors responsible for infertility in women?
• Which factors are related to the growing popularity of fresh donor eggs in IVF cycles?
• What advanced IVF treatment protocols are available in fertility clinics?
• What will be the market size and CAGR for the Asia-Pacific region during the forecast period?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Donor Egg IVF Treatment Market Portraiture
2.2. Global Donor Egg IVF Treatment Market, by Cycle Type, 2018 (US$ Mn)
2.3. Global Donor Egg IVF Treatment Market, by End User, 2018 (US$ Mn)
2.4. Global Donor Egg IVF Treatment Market, by Geography, 2018 (US$ Mn)

Chapter 3. Donor Egg IVF Treatment Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global Donor Egg IVF Treatment Market, by Key Players, 2018

Chapter 4. Global Donor Egg IVF Treatment Market, by Cycle Type
4.1. Overview
4.2. Fresh Donor Egg IVF Cycle
4.3. Frozen Donor Egg IVF Cycle

Chapter 5. Global Donor Egg IVF Treatment Market, by End User
5.1. Overview
5.2. Fertility Clinic
5.3. Hospital
5.4. Clinical Research Institute

Chapter 6. Global Donor Egg IVF Treatment Market, by Geography
6.1. Overview
6.2. North America Donor Egg IVF Treatment Market Analysis, 2017 – 2027
6.2.1. North America Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
6.2.2. North America Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
6.2.3. North America Donor Egg IVF Treatment Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Donor Egg IVF Treatment Market Analysis, 2017 – 2027
6.3.1. Europe Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
6.3.2. Europe Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Donor Egg IVF Treatment Market Analysis, 2017 – 2027
6.4.1. Asia Pacific Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Donor Egg IVF Treatment Market Analysis, 2017– 2027
6.5.1. Latin America Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
6.5.2. Latin America Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa Donor Egg IVF Treatment Market Analysis, 2017 – 2027
6.6.1. MEA Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
6.6.2. MEA Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Cook Medical, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. EMD Serono, Inc.
7.3. Flinders Reproductive Medicine Pty Ltd.
7.4. Fertility First
7.5. Genea Oxford Fertility Limited
7.6. OvaScience
7.7. Procrea Fertility
7.8. Progyny, Inc.
7.9. ReproMed
7.10. Vitrolife AB

List of Figures

FIG. 1 Donor Egg IVF Treatment Market: Research Methodology
FIG. 2 Donor Egg IVF Treatment: Market Segmentation
FIG. 3 Global Donor Egg IVF Treatment Market, by Cycle Type, 2018 (US$ Mn)
FIG. 4 Global Donor Egg IVF Treatment Market, by End User, 2018 (US$ Mn)
FIG. 5 Global Donor Egg IVF Treatment Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global Donor Egg IVF Treatment Market, by Key Players, 2018
FIG. 8 Global Fresh Donor Egg IVF Cycle Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Frozen Donor Egg IVF Cycle Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 10 Global Fertility Clinic Market for Donor Egg IVF Treatment, 2017 – 2027 (US$ Mn)
FIG. 11 Global Hospital Market for Donor Egg IVF Treatment, 2017 – 2027 (US$ Mn)
FIG. 12 Global Clinical Research Institute Market for Donor Egg IVF Treatment, 2017 – 2027 (US$ Mn)
FIG. 13 U.S. Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 14 Canada Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 15 U.K. Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 16 Germany Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 17 Rest of Europe Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 18 China Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 19 Japan Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 20 Rest of Asia Pacific Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 21 Brazil Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 22 Mexico Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 23 Rest of Latin America Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 24 GCC Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of MEA Donor Egg IVF Treatment Market, 2017 – 2027 (US$ Mn)

List of Tables

TABLE 1 Global Donor Egg IVF Treatment Market Portraiture
TABLE 2 Global Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
TABLE 3 Global Donor Egg IVF Treatment Market , by End User, 2017 – 2027 (US$ Mn)
TABLE 4 Global Donor Egg IVF Treatment Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
TABLE 6 North America Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 7 North America Donor Egg IVF Treatment Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
TABLE 9 Europe Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 10 Europe Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific Donor Egg IVF Treatment Market, by End User, 2017 – 2027 US$ Mn)
TABLE 13 Asia Pacific Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa Donor Egg IVF Treatment Market, by Cycle Type, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa Donor Egg IVF Treatment Market, by End User, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa Donor Egg IVF Treatment Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Flinders Reproductive Medicine Pty. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Fertility First: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Genea Oxford Fertility Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 OvaScience: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Procrea Fertility: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Progyny, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 ReproMed: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vitrolife AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)